{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T17:19:01Z","timestamp":1770398341543,"version":"3.49.0"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"suppl_8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,16]]},"DOI":"10.1093\/infdis\/jix356","type":"journal-article","created":{"date-parts":[[2017,7,21]],"date-time":"2017-07-21T11:07:09Z","timestamp":1500635229000},"page":"S765-S770","source":"Crossref","is-referenced-by-count":63,"title":["Immunopathogenesis of Hepatitis B Virus"],"prefix":"10.1093","volume":"216","author":[{"given":"Tai-Chung","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Rung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,11,16]]},"reference":[{"key":"key\n\t\t\t\t20171116025730_CIT0001","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00535-012-0668-y","article-title":"Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog","volume":"48","year":"2013","journal-title":"J Gastroenterol"},{"key":"key\n\t\t\t\t20171116025730_CIT0002","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171116025730_CIT0003","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/infdis\/jir687","article-title":"Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters","volume":"205","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171116025730_CIT0004","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/gast.2003.50003","article-title":"A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation","volume":"124","year":"2003","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171116025730_CIT0005","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.13.040195.000333","article-title":"Hepatitis B virus immunopathogenesis","volume":"13","year":"1995","journal-title":"Annu Rev Immunol"},{"key":"key\n\t\t\t\t20171116025730_CIT0006","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/nm.3251","article-title":"Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells","volume":"19","year":"2013","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20171116025730_CIT0007","doi-asserted-by":"crossref","first-page":"6669","DOI":"10.1073\/pnas.0401771101","article-title":"Genomic analysis of the host response to hepatitis B virus infection","volume":"101","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20171116025730_CIT0008","doi-asserted-by":"crossref","first-page":"4165","DOI":"10.1128\/JVI.74.9.4165-4173.2000","article-title":"Intrahepatic induction of alpha\/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice","volume":"74","year":"2000","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20171116025730_CIT0009","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1128\/JVI.76.6.2617-2621.2002","article-title":"Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice","volume":"76","year":"2002","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20171116025730_CIT0010","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.79.6.3851-3854.2005","article-title":"Lambda interferon inhibits hepatitis B and C virus replication","volume":"79","year":"2005","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20171116025730_CIT0011","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","article-title":"Stealth and cunning: hepatitis B and hepatitis C viruses","volume":"79","year":"2005","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20171116025730_CIT0012","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","article-title":"Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection","volume":"145","year":"1990","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20171116025730_CIT0013","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","year":"1999","journal-title":"Science"},{"key":"key\n\t\t\t\t20171116025730_CIT0014","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/jhep.2000.19324","article-title":"Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms","volume":"32","year":"2000","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171116025730_CIT0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/JVI.77.1.68-76.2003","article-title":"CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection","volume":"77","year":"2003","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20171116025730_CIT0016","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/gut.2008.163600","article-title":"Early kinetics of innate and adaptive immune responses during hepatitis B virus infection","volume":"58","year":"2009","journal-title":"Gut"},{"key":"key\n\t\t\t\t20171116025730_CIT0017","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S1074-7613(02)00305-9","article-title":"Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection","volume":"16","year":"2002","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20171116025730_CIT0018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1074-7613(00)80295-2","article-title":"Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes","volume":"4","year":"1996","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20171116025730_CIT0019","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1073\/pnas.93.10.4589","article-title":"Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver","volume":"93","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20171116025730_CIT0020","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1053\/j.gastro.2015.09.026","article-title":"Interferon-gamma and tumor necrosis factor-alpha produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171116025730_CIT0021","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0168-8278(91)90074-L","article-title":"Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B","volume":"13","year":"1991","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171116025730_CIT0022","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0016-5085(99)70289-1","article-title":"Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection","volume":"117","year":"1999","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171116025730_CIT0023","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1128\/JVI.69.6.3358-3368.1995","article-title":"Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection","volume":"69","year":"1995","journal-title":"J Virol"},{"key":"key\n\t\t\t\t20171116025730_CIT0024","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/329547a0","article-title":"Antibody production to the nucleocapsid and envelope of the hepatitis B virus primed by a single synthetic T cell site","volume":"329","year":"1987","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171116025730_CIT0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1046\/j.1365-2249.1996.d01-732.x","article-title":"Regulation of the neutralizing anti-hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection","volume":"105","year":"1996","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t20171116025730_CIT0026","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1053\/j.gastro.2009.06.054","article-title":"Temporal analysis of early immune responses in patients with acute hepatitis B virus infection","volume":"137","year":"2009","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171116025730_CIT0027","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/infdis\/jit561","article-title":"Compromised function of natural killer cells in acute and chronic viral hepatitis","volume":"209","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20171116025730_CIT0028","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20121172","article-title":"Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion","volume":"210","year":"2013","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20171116025730_CIT0029","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nm.3856","article-title":"Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells","volume":"21","year":"2015","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20171116025730_CIT0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jhep.2012.09.029","article-title":"Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B","volume":"58","year":"2013","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171116025730_CIT0031","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jhep.2013.08.020","article-title":"Reduction of HBV replication prolongs the early immunological response to IFN\u03b1 therapy","volume":"60","year":"2014","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171116025730_CIT0032","doi-asserted-by":"crossref","first-page":"e1005788","DOI":"10.1371\/journal.ppat.1005788","article-title":"Interferon alpha induces sustained changes in NK cell responsiveness to hepatitis B viral load suppression in vivo","volume":"12","year":"2016","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20171116025730_CIT0033","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa043470","article-title":"Peginterferon alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B","volume":"352","author":"Peginterferon Alfa-2a HBeAg-Positive Chronic Hepatitis B Study Group","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171116025730_CIT0034","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/ni.2573","article-title":"Intrahepatic myeloid-cell aggregates enable local proliferation of CD8(+) T cells and successful immunotherapy against chronic viral liver infection","volume":"14","year":"2013","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20171116025730_CIT0035","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1053\/j.gastro.2013.02.003","article-title":"GS-9620, an oral agonist of Toll-like receptor-7, induces prolonged suppression of hepatitis B virus in chronically infected chimpanzees","volume":"144","year":"2013","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171116025730_CIT0036","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jhep.2015.02.037","article-title":"The oral toll-like receptor-7 agonist GS-9620 in patients with chronic hepatitis B virus infection","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171116025730_CIT0037","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1084\/jem.178.5.1541","article-title":"Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis","volume":"178","year":"1993","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20171116025730_CIT0038","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1172\/JCI118902","article-title":"Long-lasting memory T cell responses following self-limited acute hepatitis B","volume":"98","year":"1996","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20171116025730_CIT0039","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.gastro.2012.06.009","article-title":"Preserved T-cell function in children and young adults with immune-tolerant chronic hepatitis B","volume":"143","year":"2012","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171116025730_CIT0040","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.immuni.2016.04.008","article-title":"Maternal-derived hepatitis B virus e antigen alters macrophage function in offspring to drive viral persistence after vertical transmission","volume":"44","year":"2016","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20171116025730_CIT0041","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1084\/jem.20151218","article-title":"Interferon-\u03b3 facilitates hepatic antiviral T cell retention for the maintenance of liver-induced systemic tolerance","volume":"213","year":"2016","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20171116025730_CIT0042","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1084\/jem.191.8.1269","article-title":"The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection","volume":"191","year":"2000","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20171116025730_CIT0043","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1053\/j.gastro.2009.09.052","article-title":"Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B","volume":"138","year":"2010","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171116025730_CIT0044","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1002\/hep.23936","article-title":"The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function","volume":"52","year":"2010","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171116025730_CIT0045","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.24249","article-title":"Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-Prone CD8 T cells in persistent hepatitis B virus infection","volume":"53","year":"2011","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171116025730_CIT0046","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nm.4275","article-title":"Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B","volume":"23","year":"2017","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20171116025730_CIT0047","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jhep.2011.12.032","article-title":"Peginterferon-\u03b1 does not improve early peripheral blood HBV-specific T-cell responses in HBeAg-negative chronic hepatitis","volume":"56","year":"2012","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171116025730_CIT0048","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/j.gastro.2012.07.014","article-title":"Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues","volume":"143","year":"2012","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20171116025730_CIT0049","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1053\/jhep.2001.23045","article-title":"Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy","volume":"33","year":"2001","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20171116025730_CIT0050","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1200\/JCO.2012.48.5938","article-title":"Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B","volume":"31","year":"2013","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20171116025730_CIT0051","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.jhep.2016.01.026","article-title":"Adaptive immunity in HBV infection","volume":"64","year":"2016","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171116025730_CIT0052","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/gutjnl-2013-305707","article-title":"Anti-HBV DNA vaccination does not prevent relapse after discontinuation of analogues in the treatment of chronic hepatitis B: a randomised trial\u2013ANRS HB02 VAC-ADN","volume":"64","author":"ANRS HB02 study group","year":"2015","journal-title":"Gut"},{"key":"key\n\t\t\t\t20171116025730_CIT0053","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jhep.2016.05.016","article-title":"Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B","volume":"65","year":"2016","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171116025730_CIT0054","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S0168-8278(17)30315-X","article-title":"A phase1 study evaluating anti-PD-1 treatment with or without GS-4774 in HBeAg negative chronic hepatitis B patients","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20171116025730_CIT0055","doi-asserted-by":"crossref","first-page":"e1003856","DOI":"10.1371\/journal.ppat.1003856","article-title":"Enhancing virus-specific immunity in vivo by combining therapeutic vaccination and PD-L1 blockade in chronic hepadnaviral infection","volume":"10","year":"2014","journal-title":"PLoS Pathog"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/suppl_8\/S765\/21796977\/jix356.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T16:49:58Z","timestamp":1692895798000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jid\/article\/216\/suppl_8\/S765\/4636138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,15]]},"references-count":55,"journal-issue":{"issue":"suppl_8","published-online":{"date-parts":[[2017,11,16]]},"published-print":{"date-parts":[[2017,11,16]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix356","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,10,15]]},"published":{"date-parts":[[2017,10,15]]}}}